Vor Biopharma Inc. (VOR) Options Statistics & Positioning

Max pain sits at $22.5 and the put/call open interest ratio is 0.94. Statistics are computed by OptiView from delayed OPRA options data and refresh every trading day.

Data as of Aug 21, 2026, 3:55 PM ET · OPRA data 15 minutes delayed · For information only — not investment advice.

Last close
$23.44
52-week range
$6.86 – $830.00
IV rank
67 / 100
Moderate
Put/call OI
0.94
Max pain
$22.5
↓ 4.0% below close
Next earnings
Nov 9, 2026

Most Active VOR Contracts

ContractExpirationDTELastIVVolume
VOR $22.5 call Nov 20, 2026 91d $5.78 5
VOR $20 put Sep 18, 2026 28d $0.95 1
VOR $12.5 call Feb 19, 2027 182d $11.30 1
VOR $30 put Feb 19, 2027 182d $11.70 500.0% 1
VOR $35 put Feb 19, 2027 182d $16.00 1
See all active VOR contracts →

Explore VOR Options Statistics

Upcoming Earnings

VOR's next expected earnings date is Nov 9, 2026.

Explore the payoff profile of option on VOR for free

Build multi-leg VOR strategies, visualize payoffs, and scan the full US options universe with OptiView.

VOR Options FAQ

When is VOR's next earnings date?

VOR's next expected earnings date is Nov 9, 2026.

How often is VOR options data on this page updated?

All VOR statistics on this page are computed by OptiView from delayed OPRA options data and refresh every trading day after the session close.

Where can I see VOR max pain, open interest, and implied volatility in detail?

OptiView publishes dedicated VOR pages for implied volatility, max pain, open interest, gamma exposure, options volume, and the most active contracts — each with charts, history, and a plain-English explanation of what the numbers mean.

Methodology. IV rank compares the current 30-day at-the-money implied volatility with its highest and lowest values over the past 52 weeks. Max pain is the strike that minimizes the total payout to option holders at expiration. The call and put walls are the strikes carrying the largest call and put open interest across all expirations. Net gamma exposure (GEX) is measured from the dealer perspective. All statistics are derived from delayed OPRA options data.

Options trading involves significant risk, and losses can exceed your initial investment. Always consult a licensed financial professional before making investment decisions. OptiView does not provide financial advice; all figures on this page are descriptive statistics, not recommendations.